Precise, Transparent, Cost-effective Personalized Cancer Care
Founded in 2005 and backed by UnitedHealth Group, Sequoia Capital, Agilent and Artiman, Cellworks has built a trans-disciplinary team of molecular biologists, cellular pathway modelers, and software technologists. The Cellworks Platform uses multi-omics modeling, computational biosimulation, and AI to predict the most efficacious therapies for individual patients — generating a Therapy Response Index (TRI) report for physicians. The platform goes beyond the one-mutation, one-drug NGS paradigm to evaluate multiple aberrations and alternative therapy options. Cellworks also assists BioPharma in improving clinical trial success rates and resurrecting failed drugs, with therapeutic focus in oncology and immunology.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
